Top Markets
#1 ADO Protocol ADO Protocol +336.48%
#2 GoPlus Security GoPlus Security +50.52%
#3 Starpower Starpower +36.17%
#4 Fake World Assets Fake World Assets +29.96%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.56%
#6 GAIB AID GAIB AID +24.67%
#7 Nockchain Nockchain +22.31%
#8 The Black Bull The Black Bull +18.45%
#9 OpenEden OpenEden +14.53%
#10 Tutorial Tutorial +12.76%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Clasificación en acciones #33050
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Precio por acción
$0.5625
Capitalización bursátil
$6.29M
Cambio (1 día)
-25.56%
Cambio (1 año)
-57.71%
País
US
Comercio Citius Pharmaceuticals, Inc. (CTXR)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Citius Pharmaceuticals, Inc. (CTXR)
La acción Citius Pharmaceuticals, Inc. (símbolo: CTXR) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 17, 2026.
Una acción CTXR comprada antes de Aug 17, 2026 equivaldría hoy a 0 acciones CTXR.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE